{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T03:49:41Z","timestamp":1783828181221,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T00:00:00Z","timestamp":1586044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T00:00:00Z","timestamp":1586044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010014","name":"Six Talent Peaks Project in Jiangsu Province","doi-asserted-by":"crossref","award":["WSW-041"],"award-info":[{"award-number":["WSW-041"]}],"id":[{"id":"10.13039\/501100010014","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>Hemorrhagic arthritis (HA) is a common disease of the musculoskeletal system caused by hemorrhage in the joints, leading to damages in the synovium and cartilage. Pure platelet-rich plasma (P-PRP) has been recently demonstrated to have anti-inflammatory and regenerative potential attributed to the various cytokines and growth factors that it contains. The aim of this study was to investigate the efficacy of P-PRP for the treatment of patients with mild and severe HA.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Autologous blood was withdrawn from the New Zealand rabbits and injected into their left and right knees to establish the HA models. The injection was performed once a week and repeated for 8\u2009weeks to establish the mild HA models and for 16\u2009weeks to establish the severe HA models. One hundred microliters of P-PRP was injected into the left HA knees, and the same volume of sterile 0.9% saline was injected into the corresponding right knees. MRI examination, H&amp;E staining, and toluidine blue staining were respectively performed to evaluate the histological difference of synovium and cartilage between the P-PRP treated and untreated mild and severe groups. Normal knees were set as the control group.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Pathological changes including tissue color, joint effusion, and synovium inflammation in the mild treated group were less severe compared to the other three experimental groups based on gross observation. The difference of joint cavity diameter between the mild treated and untreated groups was 2.67\u2009\u00b1\u20090.75\u2009mm (95%CI, 1.20\u20134.14\u2009mm), which was significantly larger than that between the severe treated and untreated groups (1.50\u2009mm\u2009\u00b1\u20090.48, 95%CI, 0.56\u20132.44\u2009mm) (mean difference in joint cavity, 1.17\u2009\u00b1\u20090.32\u2009mm; 95%CI, 0.49\u20131.85\u2009mm; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). MRI examination showed the synovitis and bone marrow edema were less severe in the treated groups compared to the corresponding untreated groups. H&amp;E staining of the synovium suggested that the inflammation was much less and the cell number was much smaller in the treated than in the untreated HA knees in regard to both the mild and severe groups. The mean difference of cell number between the mild treated and untreated groups was 307.40\u2009\u00b1\u200914.23 (95%CI, 241.54\u2013343.26; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), which was 699.20\u2009\u00b1\u200982.80 (95%CI, 508.26\u2013890.14; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) between the severe treated and untreated groups. H&amp;E staining and toluidine blue staining of the cartilage exhibited an obvious amelioration of inflammation and cartilage matrix loss after being treated with P-PRP for both groups, especially the mild group.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>P-PRP was effective for the treatment of HA by inhibiting the development of synovitis and cartilage matrix loss in the affected joints, which was particularly obvious in the early-stage HA. This study supports the view that there is a great potential of P-PRP to be considered and used as a non-operative treatment for hemorrhagic arthritis at its early stage.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13075-020-02155-6","type":"journal-article","created":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T21:02:41Z","timestamp":1586120561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pure platelet-rich plasma facilitates the repair of damaged cartilage and synovium in a rabbit hemorrhagic arthritis knee model"],"prefix":"10.1186","volume":"22","author":[{"given":"Yulun","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter V.","family":"Giannoudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong Jiong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,5]]},"reference":[{"issue":"5","key":"2155_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/PHM.0b013e3182aab72","volume":"91","author":"T Spakova","year":"2012","unstructured":"Spakova T, Rosocha J, Lacko M, Harvanova D, Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012;91(5):411\u20137.","journal-title":"Am J Phys Med Rehabil"},{"issue":"1","key":"2155_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/j.1365-2516.2012.02909.x","volume":"19","author":"A Srivastava","year":"2013","unstructured":"Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, Ludlam CA, Mahlangu JN, Mulder K, Poon MC, et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19(1):e1\u201347.","journal-title":"Haemophilia"},{"issue":"5","key":"2155_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2106\/JBJS.M.00726","volume":"96","author":"C Cavallo","year":"2014","unstructured":"Cavallo C, Filardo G, Mariani E, Kon E, Marcacci M, Pereira Ruiz MT, Facchini A, Grigolo B. Comparison of platelet-rich plasma formulations for cartilage healing: an in vitro study. J Bone Joint Surg Am. 2014;96(5):423\u20139.","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"2155_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11926-017-0652-x","volume":"19","author":"KL Bennell","year":"2017","unstructured":"Bennell KL, Hunter DJ, Paterson KL. Platelet-rich plasma for the management of hip and knee osteoarthritis. Curr Rheumatol Rep. 2017;19(5):24.","journal-title":"Curr Rheumatol Rep"},{"key":"2155_CR5","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.12659\/MSM.898218","volume":"22","author":"W-J Yin","year":"2016","unstructured":"Yin W-J, Xu H-T, Sheng J-G, An Z-Q, Guo S-C, Xie X-T, Zhang C-Q. Advantages of pure platelet-rich plasma compared with leukocyte- and platelet-rich plasma in treating rabbit knee osteoarthritis. Med Sci Monit. 2016;22:1280\u201390.","journal-title":"Med Sci Monit"},{"issue":"1","key":"2155_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/039139888701000111","volume":"10","author":"M Ferrari","year":"1987","unstructured":"Ferrari M, Zia S, Valbonesi M, Henriquet F, Venere G, Spagnolo S, Grasso MA, Panzani I. A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac surgery. Int J Artif Organs. 1987;10(1):47\u201350.","journal-title":"Int J Artif Organs"},{"issue":"4","key":"2155_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/hae.13212","volume":"23","author":"H Caviglia","year":"2017","unstructured":"Caviglia H, Landro ME, Daffunchio C, Galatro G, Douglas Price AL, Salgado P, Neme D. Platelet rich plasma for chronic synovitis treatment in patients with haemophilia. Haemophilia. 2017;23(4):613\u20139.","journal-title":"Haemophilia"},{"issue":"1","key":"2155_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.yexcr.2017.02.012","volume":"352","author":"M Moussa","year":"2017","unstructured":"Moussa M, Lajeunesse D, Hilal G, El Atat O, Haykal G, Serhal R, Chalhoub A, Khalil C, Alaaeddine N. Platelet rich plasma (PRP) induces chondroprotection via increasing autophagy, anti-inflammatory markers, and decreasing apoptosis in human osteoarthritic cartilage. Exp Cell Res. 2017;352(1):146\u201356.","journal-title":"Exp Cell Res"},{"issue":"2","key":"2155_CR9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1177\/0363546510387517","volume":"39","author":"TN Castillo","year":"2011","unstructured":"Castillo TN, Pouliot MA, Kim HJ, Dragoo JL. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med. 2011;39(2):266\u201371.","journal-title":"Am J Sports Med"},{"issue":"5","key":"2155_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.arthro.2014.02.020","volume":"30","author":"J Magalon","year":"2014","unstructured":"Magalon J, Bausset O, Serratrice N, Giraudo L, Aboudou H, Veran J, Magalon G, Dignat-Georges F, Sabatier F. Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model. Arthroscopy. 2014;30(5):629\u201338.","journal-title":"Arthroscopy"},{"key":"2155_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exger.2019.01.018","volume":"119","author":"CPC Chen","year":"2019","unstructured":"Chen CPC, Chen J-L, Hsu C-C, Pei Y-C, Chang W-H, Lu H-C. Injecting autologous platelet rich plasma solely into the knee joint is not adequate in treating geriatric patients with moderate to severe knee osteoarthritis. Exp Gerontol. 2019;119:1\u20136.","journal-title":"Exp Gerontol"},{"issue":"4","key":"2155_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/JSA.0000000000000007","volume":"21","author":"RP Russell","year":"2013","unstructured":"Russell RP, Apostolakos J, Hirose T, Cote MP, Mazzocca AD. Variability of platelet-rich plasma preparations. Sports Med Arthrosc Rev. 2013;21(4):186\u201390.","journal-title":"Sports Med Arthrosc Rev"},{"issue":"5","key":"2155_CR13","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1111\/hae.12743","volume":"21","author":"KC Wang","year":"2015","unstructured":"Wang KC, Amirabadi A, Wang KC, Moineddin R, Jong R, Tomlinson C, Doria AS. Longitudinal assessment of bone loss using quantitative ultrasound in a blood-induced arthritis rabbit model. Haemophilia. 2015;21(5):e402\u201310.","journal-title":"Haemophilia"},{"issue":"1","key":"2155_CR14","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1111\/hae.13090","volume":"23","author":"A Shammas","year":"2017","unstructured":"Shammas A, Doria AS, Amirabadi A, Gahunia H, Jong R, Charron M, Moineddin R, Metser U. Pilot study on (18) F-FDG PET\/CT for detection of inflammatory changes in blood-induced knee arthropathy in a rabbit model. Haemophilia. 2017;23(1):e25\u201332.","journal-title":"Haemophilia"},{"issue":"9","key":"2155_CR15","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/art.1780310910","volume":"31","author":"R Madhok","year":"1988","unstructured":"Madhok R, Bennett D, Sturrock RD, Forbes CD. Mechanisms of joint damage in an experimental model of hemophilic arthritis. Arthritis Rheumatism. 1988;31(9):1148\u201355.","journal-title":"Arthritis Rheumatism"},{"issue":"3","key":"2155_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tibtech.2008.11.009","volume":"27","author":"DM Dohan Ehrenfest","year":"2009","unstructured":"Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27(3):158\u201367.","journal-title":"Trends Biotechnol"},{"issue":"5","key":"2155_CR17","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1007\/s00266-012-9957-3","volume":"36","author":"D Franco","year":"2012","unstructured":"Franco D, Franco T, Schettino AM, Filho JM, Vendramin FS. Protocol for obtaining platelet-rich plasma (PRP), platelet-poor plasma (PPP), and thrombin for autologous use. Aesthet Plast Surg. 2012;36(5):1254\u20139.","journal-title":"Aesthet Plast Surg"},{"issue":"10","key":"2155_CR18","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1177\/0363546519856605","volume":"47","author":"DK Chouhan","year":"2019","unstructured":"Chouhan DK, Dhillon MS, Patel S, Bansal T, Bhatia A, Kanwat H. Multiple platelet-rich plasma injections versus single platelet-rich plasma injection in early osteoarthritis of the knee: an experimental study in a guinea pig model of early knee osteoarthritis. Am J Sports Med. 2019;47(10):2300\u20137.","journal-title":"Am J Sports Med"},{"issue":"4","key":"2155_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2559.2006.02508.x","volume":"49","author":"V Krenn","year":"2006","unstructured":"Krenn V, Morawietz L, Burmester GR, Kinne RW, Mueller-Ladner U, Muller B, Haupl T. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology. 2006;49(4):358\u201364.","journal-title":"Histopathology"},{"key":"2155_CR20","doi-asserted-by":"publisher","unstructured":"Andia I, Maffulli N. Blood-derived products for tissue repair\/regeneration. Int J Mol Sci. 2019;20(18):4581. https:\/\/doi.org\/10.3390\/ijms20184581.","DOI":"10.3390\/ijms20184581"},{"key":"2155_CR21","doi-asserted-by":"publisher","unstructured":"Tan HB, Giannoudis PV, Boxall SA, McGonagle D, Jones E. The systemic influence of platelet-derived growth factors on bone marrow mesenchymal stem cells in fracture patients. BMC Med. 2015;13(1):6. https:\/\/doi.org\/10.1186\/s12916-014-0202-6.","DOI":"10.1186\/s12916-014-0202-6"},{"key":"2155_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jot.2017.03.006","volume":"9","author":"L Kong","year":"2017","unstructured":"Kong L, Zheng LZ, Qin L, Ho KKW. Role of mesenchymal stem cells in osteoarthritis treatment. J Orthop Translat. 2017;9:89\u2013103.","journal-title":"J Orthop Translat"},{"key":"2155_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1741-7015-10-81","volume":"10","author":"R Dimitriou","year":"2012","unstructured":"Dimitriou R, Mataliotakis GI, Calori GM, Giannoudis PV. The role of barrier membranes for guided bone regeneration and restoration of large bone defects: current experimental and clinical evidence. BMC Med. 2012;10:81.","journal-title":"BMC Med"},{"issue":"4","key":"2155_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/14712598.2018.1424626","volume":"18","author":"I Andia","year":"2018","unstructured":"Andia I, Martin JI, Maffulli N. Advances with platelet rich plasma therapies for tendon regeneration. Expert Opin Biol Ther. 2018;18(4):389\u201398.","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"2155_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1365-2184.2009.00583.x","volume":"42","author":"E Anitua","year":"2009","unstructured":"Anitua E, Sanchez M, Zalduendo MM, de la Fuente M, Prado R, Orive G, Andia I. Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif. 2009;42(2):162\u201370.","journal-title":"Cell Prolif"},{"issue":"4","key":"2155_CR26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.bone.2003.12.010","volume":"34","author":"G Weibrich","year":"2004","unstructured":"Weibrich G, Hansen T, Kleis W, Buch R, Hitzler WE. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone. 2004;34(4):665\u201371.","journal-title":"Bone"},{"issue":"1","key":"2155_CR27","first-page":"11","volume":"80","author":"P Teyssler","year":"2014","unstructured":"Teyssler P, Kolostova K, Bobek V. The impact of platelet-rich plasma on chronic synovitis in hemophilia. Acta Orthop Belg. 2014;80(1):11\u20137.","journal-title":"Acta Orthop Belg"},{"key":"2155_CR28","doi-asserted-by":"crossref","unstructured":"Fadadu PP, Mazzola AJ, Hunter CW, Davis TT. Review of concentration yields in commercially available platelet-rich plasma (PRP) systems: a call for PRP standardization. Reg Anesth Pain Med. 2019;44(6):652\u20139.","DOI":"10.1136\/rapm-2018-100356"},{"issue":"5","key":"2155_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2174\/138945010791011938","volume":"11","author":"KB Marcu","year":"2010","unstructured":"Marcu KB, Otero M, Olivotto E, Borzi RM, Goldring MB. NF-kappaB signaling: multiple angles to target OA. Curr Drug Targets. 2010;11(5):599\u2013613.","journal-title":"Curr Drug Targets"},{"key":"2155_CR30","first-page":"1","volume":"2018","author":"J Jia","year":"2018","unstructured":"Jia J, Wang S-Z, Ma L-Y, Yu J-B, Guo Y-D, Wang C. The differential effects of leukocyte-containing and pure platelet-rich plasma on nucleus pulposus-derived mesenchymal stem cells: implications for the clinical treatment of intervertebral disc degeneration. Stem Cells Int. 2018;2018:1\u201312.","journal-title":"Stem Cells Int"},{"issue":"6","key":"2155_CR31","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1189\/jlb.1012512","volume":"93","author":"ML Novak","year":"2013","unstructured":"Novak ML, Koh TJ. Macrophage phenotypes during tissue repair. J Leukoc Biol. 2013;93(6):875\u201381.","journal-title":"J Leukoc Biol"},{"issue":"11","key":"2155_CR32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri3073","volume":"11","author":"PJ Murray","year":"2011","unstructured":"Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011;11(11):723\u201337.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"2155_CR33","doi-asserted-by":"publisher","first-page":"980","DOI":"10.2106\/JBJS.L.00266","volume":"95","author":"S Terada","year":"2013","unstructured":"Terada S, Ota S, Kobayashi M, Kobayashi T, Mifune Y, Takayama K, Witt M, Vadala G, Oyster N, Otsuka T, et al. Use of an antifibrotic agent improves the effect of platelet-rich plasma on muscle healing after injury. J Bone Joint Surg Am. 2013;95(11):980\u20138.","journal-title":"J Bone Joint Surg Am"},{"issue":"9","key":"2155_CR34","doi-asserted-by":"publisher","first-page":"6066","DOI":"10.1167\/iovs.11-7302","volume":"52","author":"E Anitua","year":"2011","unstructured":"Anitua E, Sanchez M, Merayo-Lloves J, De la Fuente M, Muruzabal F, Orive G. Plasma rich in growth factors (PRGF-Endoret) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts and inhibits and reverts TGF-beta1-induced myodifferentiation. Invest Ophthalmol Vis Sci. 2011;52(9):6066\u201373.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"2155_CR35","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1902\/jop.2011.110505","volume":"83","author":"E Anitua","year":"2012","unstructured":"Anitua E, Troya M, Orive G. Plasma rich in growth factors promote gingival tissue regeneration by stimulating fibroblast proliferation and migration and by blocking transforming growth factor-beta1-induced myodifferentiation. J Periodontol. 2012;83(8):1028\u201337.","journal-title":"J Periodontol"},{"issue":"9","key":"2155_CR36","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1177\/0363546514540272","volume":"42","author":"D Delos","year":"2014","unstructured":"Delos D, Leineweber MJ, Chaudhury S, Alzoobaee S, Gao Y, Rodeo SA. The effect of platelet-rich plasma on muscle contusion healing in a rat model. Am J Sports Med. 2014;42(9):2067\u201374.","journal-title":"Am J Sports Med"},{"key":"2155_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.biomaterials.2016.02.017","volume":"87","author":"H Li","year":"2016","unstructured":"Li H, Hicks JJ, Wang L, Oyster N, Philippon MJ, Hurwitz S, Hogan MV, Huard J. Customized platelet-rich plasma with transforming growth factor beta1 neutralization antibody to reduce fibrosis in skeletal muscle. Biomaterials. 2016;87:147\u201356.","journal-title":"Biomaterials"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02155-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-020-02155-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02155-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T23:09:09Z","timestamp":1617577749000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-02155-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,5]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2155"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-02155-6","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,5]]},"assertion":[{"value":"14 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments conformed to the animal welfare guidelines under approved protocols of The First Affiliated Hospital of Soochow University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}